What are the Limitations of Using Troponin as a Biomarker in Cancer?
While troponin is a valuable biomarker, there are some limitations: - Specificity: Elevated troponin levels are not exclusive to cardiotoxicity and can be seen in other conditions such as renal failure and sepsis. - Baseline Variability: Cancer patients may have varying baseline troponin levels due to pre-existing cardiac conditions, making it challenging to interpret changes accurately. - Temporal Changes: Troponin levels can fluctuate over time, requiring continuous monitoring for accurate assessment.
